Complex therapy of chronic hepatic encephalopathy completed with probiotic: Comparison of two studies;Komplexná liečba chronickej hepatálnej encefalopatie doplnená probiotikom: Porovnanie dvoch štúdií

Casopis Lekaru Ceskych

Volumn 143, Issue 5, 2004, Pages 324-328

  Boča, Milan ^a   Vyskocil M ^a   Mikulecky M ^a   Ebringer, L ^c   Kolibas E ^b   Kratochvil'ova H ^a   Buzgova D ^a  

^a I Interna Klinika   (Slovakia)

^b Psychiatricka Klinika   (Slovakia)

^c Fakulty UK   (Slovakia)

Author keywords

Blood ammonia; Chronic hepatic encephalopathy; Enterococcus faecium M 74 + Selenium; Hepatic cirrhosis; Number connecting test; Portal systemic encephalopathy index

Indexed keywords

PROBIOTIC AGENT; SELENIUM;

AMMONIA BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS FAECIUM; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; REVIEW; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; CHRONIC DISEASE; ENTEROCOCCUS FAECIUM; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROBIOTICS; SELENIUM;

EID: 16644397181     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Schrezenmeir, J., de Vreese, M.: Probiotics, prebiotics and synbiotics - aproaching and definition. Am. J. Clin. Nutr., 2001, 73 (Suppl.), s. 361-364.
2. Ebringer, L., Ferenčík, M., Mikeš, Z.: Črevná mikroflóra, imunitný systém a atopické ochorenia. Derma, 2002, 2, s. 9-19.
3. Marteau, P., Marteau, P., Boutron-Rualt, M. C.: Nutritional advantages of probiotics and prebiotics. Br. J. Nutr., 2002, 87 (Suppl 2), s. 153-157.
4. Ferenčík, M., Ebringer, L., Mikeš, Z. et al.: Beneficial modification of the human intestinal microflora using orally administered lactic acid bacteria. Bratislav. Lek. Listy. 1999, 100, s. 238-245.
5. Conn, H. O.: Hepatic encephalopathy. In: Disease of the Liver. Schiff, L., Shiff, E. R. (eds.) Seventh Edition, 2 vol. J.B. Lippincott Company, 1993, 1516, s. 106-1060.
6. Hazell, A. S, Buterworth, R. F.: Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med., 1999, Nov. 222/2, s. 99-112.
7. Blei, A. T, Cordoba, J.: Hepatic encephalopathy. Am. J. Gastroenterol., 2001, 99, s. 1968-1976.
8. Loguercio, C., Abbiati, R., Rinaldo, M. et al.: Long term effects of Enterococcus faecium SF 68 versus lactulose in the treatmnet of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J. Hepatology, 1995, 23, s. 39-46.
9. Conn, H. O, Lieberthal, M. M.: The Hepatic Coma Syndromes and Lactulose. Baltimore-London, Wiliams and Wilkins, 1980, s. 185.
10. Mareček, Z., Brůha, R.: The clinical spectrum of hepatic encephalopathy. Progress in Hepato-Pharmacology, 1995, 1, s. 94-98.
11. Bircher, J., Muller, J., Geggenheim, P. et al.: Treatment of chronical portal systemic encephalopathy with lactulose. Lancet, 1966, 1, s. 890 až 892.
12. Bircher, J., Buhrer, M., Franz, K. et al.: Erstmalige Anwendung von Lactitol in der Behandlung der portosistemischen Enzephalopathie. Schweiz. med. Wschr, 1982, 112, s. 1306-1307.
13. Ebringer, L., Ferenčík, M., Mikeš, Z., Duriš, I.: Prebiotiká a ich účinky na črevnú mikroflóru. Derma, 2002, 2, s. 10-17.
14. Boča, M., Ďuriš, I., Kolibáš, E., Kratochvíl'ová, E.: Lactitol, Importal prášok 10 g ZYMA, v liečbe portálnej systémovej encefalopatie. Vnitř. Lék., 1996, 42, s. 234-238.
15. Nanji, A. A., Khettry, U., Sadrzadeh, S. M. H.: Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med., 1994, 205, s. 243-247.